Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
APMIS ; 114(5): 338-44, 2006 May.
Article in English | MEDLINE | ID: mdl-16725009

ABSTRACT

Mycoplasma pneumoniae (MP) and Chlamydophila pneumoniae (CP) antigens are encountered in complicated atheromas and may be implicated in the diversity of atherosclerotic lesions. Mycoplasma can downregulate the immune system, altering levels of inflammation, which may favor the proliferation of other co-infectious agents. In the present study we analyze whether initially stable human atheromas exhibit different ratios of MP/CP antigens compared to ongoing atheromatous lesions. Two groups were examined for the presence of inflammatory cells, macrophages, growth factors and infectious agents: Group I (GI), n=16, early stable atheromas, <4 CD68(+) macrophages/400 x field, showing a normal distribution and a fibrous cap; Group II (GII), n=14, growing atheromas, > or =4 CD68+ cells/400 x field, lacking a fibrous cap, showing a non-normal macrophage distribution. The amounts of CP (but not MP) antigens and lymphocytes in GI were significantly lower than in GII. MP/CP ratios were higher in GI. MP correlated with CP and PDGFB in GI (r=0.79 and r=0.83, p<0.001), but not in GII (r=-0.4 and r=-0.08, p=0.81). MP and CP antigens are already present in early atheromas, and a higher MP/CP ratio correlates with increased growth factors, lower inflammation and plaque stability.


Subject(s)
Chlamydophila Infections/complications , Chlamydophila pneumoniae/isolation & purification , Coronary Artery Disease/diagnosis , Coronary Artery Disease/microbiology , Mycoplasma pneumoniae/isolation & purification , Pneumonia, Mycoplasma/complications , Adult , Aged , Aged, 80 and over , Antigens, Bacterial/analysis , Antigens, CD/metabolism , Antigens, Differentiation, Myelomonocytic/metabolism , Cell Count , Chlamydophila pneumoniae/immunology , Coronary Artery Disease/pathology , Coronary Vessels/microbiology , Coronary Vessels/pathology , Disease Progression , Female , Humans , Immunohistochemistry , Inflammation/pathology , Macrophages/cytology , Macrophages/pathology , Male , Middle Aged , Mycoplasma pneumoniae/immunology , Platelet-Derived Growth Factor/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...